News

and Press

Sign up now for the latest IR news, and updates on ongoing developments at Avicanna Inc:

    Avicanna´s Majority Owned Colombian Subsidiary Attains 2021 THC Production Quota and Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Chile
    Avicanna to Participate in Benzinga Biotech Small Cap Conference and the Virtual Life Sciences Investor Forum both taking place on Thursday March 25th
    Avicanna Enters Strategic Partnership with Al Harrington’s, Viola, for commercialization of Viola branded products in Canada
    Avicanna Closes Non-Brokered Private Placement Raising $5.6 Million.
    Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the United States
    Avicanna Launches RHO Phyto™ Topical Gels in Canada and Initiates Clinical Studies
    Avicanna Initiates Pre-Clinical and Behavioural Studies on its RHO Phyto™ Formulary with University of Guelph and Provides Research and Management Team Updates
    Avicanna Advances Pharmaceutical Epilepsy Program with Collaboration with The University Health Network and GMP Manufacturing Of Its First Pharmaceutical Preparation
    Avicanna Announces Exercise And Closing Of Over-Allotment Option
    Avicanna To Expand Access To Its Advanced And Evidence-based Rho Phyto Medical Products Through Provincial Retailers Across Canada
    Avicanna Expands Distribution Network In South America Through Commercial Partnerships In Ecuador And Commercial Export Of Feminized Seeds To Uruguay
    Avicanna Launches Medical Cannabis Program With Its Rho Phyto™ Formulary Nationwide In Colombia